1. Dr. Pier Mannuccio Mannucci. Hematology Expert. Biography. 0
Dr. Pier Mannucci, MD, explains advances in hemophilia and von Willebrand disease treatment. He discusses the genetic links between blood clots and undiagnosed cancer.
▶⏸
2. VITT. vaccine-induced thrombotic thrombocytopenia and COVID-19 vaccination. 11. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains the rare but serious condition of vaccine-induced thrombotic thrombocytopenia (VITT). He details the unique pathophysiology of VITT, which causes both...
▶⏸
3. Chronic liver disease. How to use laboratory tests correctly? 1
Dr. Pier Mannucci, MD, explains how to correctly interpret coagulation tests. He clarifies that abnormal prothrombin time does not predict bleeding risk in liver patients....
▶⏸
4. Blood clots risk and mutations. Do a genetic test or not? 4. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains the limited clinical utility of genetic testing for blood clot risk mutations. He details how common mutations like Factor V...
▶⏸
5. Personalized nutrition. How to choose real food well? 8. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains how personalized nutrition tailors diet to individual health risks. He emphasizes that food processing is more critical than macronutrient composition....
▶⏸
6. Air pollution and heart disease. How to lower your risks? 9. [Parts 1 and 2]
Dr. Anton Titov, MD, explores practical strategies for individuals to lower their personal exposure risks in urban environments.
▶⏸
7. Polypharmacy in elderly patients. Why doctors prescribe too many drugs? 10. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains why elderly patients are prescribed too many medications. He details the severe risks of polypharmacy, including adverse drug events and...
▶⏸
8. Von Willebrand disease. New treatment options. MGUS. Acquired VWD. 2
Dr. Pier Mannuccio Mannucci, MD, covers the importance of specialist referral for accurate diagnosis. Von Willebrand disease is the most common inherited bleeding disorder.
▶⏸
9. Hemophilia. New treatment options. Emicizumab. Gene therapy. 3 [Part 1 and 2]
Dr. Anton Titov, MD, facilitates this in-depth discussion on precision medicine for hemophilia.
▶⏸
10. Deep vein thrombosis and cancer risk. Heparin and aspirin in DVT. 5
Dr. Pier Mannucci, MD, explains the complex relationship between cancer and blood clots. He details the use of low molecular weight heparin and direct oral...
▶⏸
11. Direct oral anticoagulants or vitamin K antagonists? When to use? 6
Dr. Pier Mannucci, MD, explains the advantages of direct oral anticoagulants over older vitamin K antagonists. He details the superior convenience and safety profile of...
▶⏸
12. Atrial fibrillation in elderly patients. Thrombosis vs. bleeding risk. 7
Dr. Pier Mannucci, MD, explains the critical balance between stroke prevention and bleeding risk in elderly atrial fibrillation patients. He emphasizes that stroke risk significantly...
▶⏸
13. MGUS and acquired von Willibrand syndrome. 12
Dr. Anton Titov, MD, explores the rare but serious complication of bleeding from acquired von Willebrand disease.
Refine your treatment plan with a panel of top doctors who precisely fit your case.